Clinical Pharmacology Of Metabolism-Activating And Correcting Drugs

dc.contributor.author	Urinboev L.X.
dc.date.accessioned	2026-01-01T10:19:26Z
dc.date.issued	2025-03-12
dc.description.abstract	The article covers the issues of drug metabolism in patients with various liver diseases, presents pathophysiological mechanisms of impaired biotransformation of substances depending on the severity of hepatocyte damage, names the causes of drug interactions of pharmacological agents, leading to an undesirable increase in the concentration of the drug in the blood, strengthening and prolongation of the therapeutic effect with an increased risk of side effects
dc.format	application/pdf
dc.identifier.uri	https://zienjournals.com/index.php/tjms/article/view/6016
dc.identifier.uri	10.62480/tjms.2025.vol42.pp48-50
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/59967
dc.language.iso	eng
dc.publisher	Zien Journals
dc.relation	https://zienjournals.com/index.php/tjms/article/view/6016/4897
dc.rights	https://creativecommons.org/licenses/by-nc/4.0
dc.source	Texas Journal of Medical Science; Vol. 42 (2025): TJMS; 48-50
dc.source	2770-2936
dc.subject	therapeutic action
dc.subject	biotransformation of substances
dc.title	Clinical Pharmacology Of Metabolism-Activating And Correcting Drugs
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: lx_2025_clinical_pharmacology_of_metabolism-acti.pdf
item.page.filesection.size: 193.68 KB
item.page.filesection.format: Adobe Portable Document Format